| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/04/2002 | CA2431916A1 New therapeutic uses of smr1 peptides |
| 07/04/2002 | CA2431913A1 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | CA2431835A1 Induction of tolerance |
| 07/04/2002 | CA2431478A1 Synovial cell protein |
| 07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | CA2430610A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | CA2429773A1 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | CA2399280A1 Defects in periaxin associated with myelinopathies |
| 07/03/2002 | EP1219711A2 Lawsonia intracellularis vaccine |
| 07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
| 07/03/2002 | EP1219709A1 Nucleozymes |
| 07/03/2002 | EP1219706A2 Production processes for recombinant wolinella succinogenes asparaginase |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219637A1 Polypeptides having a triggering NK activity and biological applications |
| 07/03/2002 | EP1219636A2 Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms |
| 07/03/2002 | EP1219635A2 Chlamydia pneumoniae antigenes |
| 07/03/2002 | EP1219634A1 Cytostatic-glycoconjugates having specifically cleavable peptidic linking units |
| 07/03/2002 | EP1219305A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
| 07/03/2002 | EP1219303A1 Chondrogenesis promoters |
| 07/03/2002 | EP1219301A1 Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218527A2 Adenoviral vectors for treating disease |
| 07/03/2002 | EP1218521A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218514A1 Designing immunogens |
| 07/03/2002 | EP1218511A1 Antimicrobial compositions |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218508A1 Gene treatment to enhance feed efficiency and growth rate of livestock |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218503A2 Fatty acid transport proteins |
| 07/03/2002 | EP1218498A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 07/03/2002 | EP1218496A2 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 07/03/2002 | EP1218494A2 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 07/03/2002 | EP1218493A1 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218411A2 Secreted proteins and uses thereof |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218407A1 Uses of kappa-conotoxin pviia |
| 07/03/2002 | EP1218406A1 Nucleic acids and secreted polypeptides encoded thereby |
| 07/03/2002 | EP1218405A2 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
| 07/03/2002 | EP1218404A1 A binding motif of a receptor |
| 07/03/2002 | EP1218403A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 07/03/2002 | EP1218400A1 Compositions and methods for the diagnosis and treatment of immune disorders |
| 07/03/2002 | EP1218398A1 Antisense modulation of pi3 kinase p110 beta expression |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218395A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218064A2 Compositions for treating autoimmune disease containing a compounds which regulates icam-lfa-1 interaction and a compounds which regulates cd40-cd40 ligand interaction |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218027A2 Composition for stabilizing corneal tissue during or after orthokeratological lens wear |
| 07/03/2002 | EP1218026A2 Method to enhance healing of sternum after sternotomy |
| 07/03/2002 | EP1218025A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 07/03/2002 | EP1218024A2 Viscosity modulating substance and use thereof |
| 07/03/2002 | EP1218019A2 Oncolytic virus |
| 07/03/2002 | EP1218018A2 Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators |
| 07/03/2002 | EP1218011A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 07/03/2002 | EP1217993A2 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 07/03/2002 | EP1217990A1 Cationic dosper virosomes |
| 07/03/2002 | EP1217988A1 Proteinic drug delivery system using membrane mimetics |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP1012174A4 Nik proteins, nucleic acids and methods |
| 07/03/2002 | EP0971729B1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin |
| 07/03/2002 | EP0938326A4 Synthetic phosphopeptides for treating bone diseases |
| 07/03/2002 | EP0935468B1 Use of cytokines and cytotoxic substances in a new method to treat tumors |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | EP0754054B1 Antirestenosis protein |
| 07/03/2002 | EP0637248B1 Pharmaceutical composition containing cyclosporin derivative |
| 07/03/2002 | EP0619324B1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357049A Receptor based antagonists and mehtods of making and using |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357047A Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357042A Interleukin-17 related mammalian cytokines, polynucleotides encoding them. uses |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1357007A Expression of heparin-binding protein in recombinant mammalian cells |
| 07/03/2002 | CN1357006A Mage-A1 peptides presented by HLA class II molecules |
| 07/03/2002 | CN1357000A Water soluble prodrugs of hindered alcohols or phenols |
| 07/03/2002 | CN1356913A Vitronectic receptor antagonist pharmaceuticals |
| 07/03/2002 | CN1356910A Model membrane systems |
| 07/03/2002 | CN1356909A Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody |
| 07/03/2002 | CN1356908A Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356906A Therapeutic methods and compsns. for treatment of in paired interpersonal and behavioral disorders |
| 07/03/2002 | CN1356883A Vacuum assisted closure system with provision for introduction of agent |
| 07/03/2002 | CN1356338A Separation, synthesis and application in medicine for P6A'S metabolic product |
| 07/03/2002 | CN1356141A Process for preparing injection liquid of brain protein hydrolyzate |
| 07/02/2002 | US6414134 Regulation of bcl-2 gene expression |
| 07/02/2002 | US6414131 Nucleic acid sequence; schizophrenia, bipolar disorder and depression |
| 07/02/2002 | US6414130 Polypeptides binds to extracellular domain, glycosylated polypeptide or monoclonal antibody; antitumor agents |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |